Peritoneal Dialysis in Patients With Ascites: Is it an Option?
Many of my personal patient encounters over the past years are near mirror images of the vignette discussed in a recent AJKD In Practice article from Rajora et al. A [...]
Commentary
Commentaries are short perspectives by experts on AJKD articles or nephrology news.
Pharmacotherapy for the Nephrologist: From Anticoagulants to Anti-hypertensives
A recent AJKD Core Curriculum from Vondracek et al tackles the broad topic of pharmacotherapy. In this piece, the authors discuss basic principles and give a comprehensive [...]
Is new always better? Apixaban vs. Warfarin and CKD Progression
Atrial fibrillation (AF) is the most common arrhythmia in patients with chronic kidney disease (CKD), with a prevalence of nearly 24.5%. This is over 2 times higher than [...]
Association of Blood Pressure With the Progression of CKD: Are We Any Further Forward?
Lowering blood pressure (BP) is beneficial in patients with chronic kidney disease (CKD) from a cardiovascular protection point of view, and has formed the basis of our [...]
On Arguments of Race and Estimated GFR
Update: The Final Report was published on September 23, 2021. A Special Report published in AJKD highlights an interim report from the joint NKF/ASN Task Force on the [...]
HCV D+/R- Kidney Transplantation in the Real-World: Is It Time?
The emergence of direct acting antiviral (DAA) therapy for hepatitis C (HCV) has arguably been one of the most exciting developments in kidney transplantation in the United [...]
Will You Take the Blue or Red Pill?
Calcium channel blockers (CCBs) and renin-angiotensin-system inhibitors (RASi) are two classes of antihypertensive medications frequently used as initial therapy for [...]
Could High Be Better Than Low? Targeting Phosphate in Trials
Phosphate is bad, right? As kidney function declines, phosphate excretion goes down. Serum phosphate levels rise, causing parathyroid hormone (PTH) to increase and bring [...]
A Patient Behavior Modification to Increase Fluid Intake: The PUSH Trial
With the prevalence of urinary stone disease (USD) nearly doubling over the last 15 years, there has been a concomitant rise in the impact it has on our healthcare system. [...]
Primary FSGS: Using Proteinuria as an Endpoint
Focal segmental glomerulosclerosis (FSGS) is a histologic description with numerous etiologies and proposed pathogenic mechanisms. Proteinuria, frequently associated with [...]